Zymeworks Inc. (ZYME)
NASDAQ: ZYME · IEX Real-Time Price · USD
8.48
+0.05 (0.59%)
May 31, 2024, 4:00 PM EDT - Market closed

Zymeworks Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018 - 2014
Revenue
76.01412.4826.6838.9529.54
Upgrade
Revenue Growth (YoY)
-81.57%1446.03%-31.50%31.84%-44.28%
Upgrade
Gross Profit
76.01412.4826.6838.9529.54
Upgrade
Selling, General & Admin
70.4573.3642.5655.2262.71
Upgrade
Research & Development
143.62208.6199.75171.2117.37
Upgrade
Other Operating Expenses
00000.77
Upgrade
Operating Expenses
214.07281.95242.31226.42180.85
Upgrade
Operating Income
-138.05130.53-215.63-187.47-151.3
Upgrade
Other Expense / Income
-18.81-4.71-3.27-7.35-5.28
Upgrade
Pretax Income
-119.24135.23-212.36-180.12-146.02
Upgrade
Income Tax
-0.5710.89-0.520.43-0.58
Upgrade
Net Income
-118.67124.34-211.84-180.55-145.44
Upgrade
Shares Outstanding (Basic)
6965525038
Upgrade
Shares Outstanding (Diluted)
6965525038
Upgrade
Shares Change
5.54%25.16%3.47%32.51%30.71%
Upgrade
EPS (Basic)
-1.721.91-4.11-3.58-3.83
Upgrade
EPS (Diluted)
-1.721.90-4.61-3.58-3.83
Upgrade
Free Cash Flow
-120.78135.96-204.86-155.71-88.18
Upgrade
Free Cash Flow Per Share
-1.752.08-3.97-3.09-2.32
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-181.62%31.64%-808.22%-481.29%-512.12%
Upgrade
Profit Margin
-156.13%30.14%-794.01%-463.54%-492.27%
Upgrade
Free Cash Flow Margin
-158.89%32.96%-767.82%-399.77%-298.45%
Upgrade
Effective Tax Rate
-8.05%---
Upgrade
EBITDA
-101.94147.24-202.78-169.84-138.69
Upgrade
EBITDA Margin
-134.11%35.70%-760.03%-436.05%-469.43%
Upgrade
Depreciation & Amortization
17.31129.5810.287.33
Upgrade
EBIT
-119.24135.23-212.36-180.12-146.02
Upgrade
EBIT Margin
-156.87%32.79%-795.95%-462.43%-494.24%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).